Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
Clinical trial NCT02959437 · TERMINATED
Trial details
- NCT number
- NCT02959437
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2019-02-15
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.